Mag 2 Magnesio Pidolato

Mag 2 is a well-known therapeutic brand for magnesium supplementation, specifically utilizing Magnesium Pidolate for high absorption. Launched originally in Italy by Sanofi, it is a staple in Italian pharmacies for addressing magnesium deficiency symptoms like fatigue and muscle cramps. The product shown is a single-dose oral solution. Although Sanofi originated the brand, in recent years it transitioned through Sanofi's Consumer Healthcare division (Opella). Opella is undergoing a significant ownership change as the French private equity firm Clayton, Dubilier & Rice (CD&R) has entered into exclusive negotiations to acquire a controlling stake from Sanofi, aiming to manage it as a standalone global consumer healthcare leader from 2025/2026 onwards.